Stay Ahead with the Latest BP Treatment Strategies

Discussions on effective hypertension management are set to intensify with the release of new guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA). Around 26% to 30% of adults in Egypt are estimated to have hypertension (HTN), defined as a blood pressure of 130/80 mm Hg or higher. Thankfully, blood pressure categories remain unchanged.

NPS-adv

It's important to personalize blood pressure goals for each patient. For most individuals, aim for a target below 130/80 mm Hg, and if feasible, strive for a goal under 120/80 mm Hg. However, this strict target may not be appropriate for everyone. For example, for patients with limited life expectancy or those in long-term care due to frailty, a more relaxed goal of under 140/90 or even 150/90 may be safer.

Use this summary and your clinical judgment to treat high blood pressure.

* Am Heart Assn’s Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) calculator.

Blood Pressure (mm Hg)	ACC/AHA Guideline Treatment Recommendations
Normal: <120/80	Maintain healthy lifestyle habits
Elevated: 120 - 129/<80	Encourage lifestyle changes (exercise, weight loss, reduce dietary sodium, etc) Check for meds (NSAIDs, decongestants, etc) or conditions (sleep apnea, etc) that can increase BP and address if needed
Stage 1 hypertension: 130 - 139/80 - 89	Implement lifestyle changes Start a BP med for patients with CV disease (stroke, heart failure, etc), chronic kidney disease, diabetes, or 10-year PREVENT-CVD* risk ≥7.5% If 10-year PREVENT-CVD* risk <7.5% and average BP remains ≥130/80 after 3 – 6 months of lifestyle changes, then start a BP med
Stage 2 hypertension: ≥140/90	Reinforce lifestyle changes Use 2 BP meds (ideally a single-pill combo) for most patients

NPS-adv

Start with BP meds that improve outcomes; thiazides, ACEIs or ARBs, or long-acting dihydropyridine calcium channel blockers (amlodipine, etc). Use a generic single-pill combo for most patients with stage 2 hypertension, if you don’t already. Most patients will need more than 1 medication and using combos may help boost adherence and offset side effects.

For instance, an ACEI or ARB may counteract peripheral edema due to CCBs or an ACEI or ARB may reduce risk of hypokalemia due to a thiazide. Approval has been granted by the FDA for the single-pill combo Widaplik (telmisartan/amlodipine/indapamide), touted to improve adherence. However, cost may be a barrier.

Encourage home BP monitoring with a properly sized arm monitor validated for accuracy to evaluate BP control and limit overtreatment. For example, watch BP closely for patients with significant weight reduction or improved exercise. They may need lower BP med doses. Prepare to check for primary aldosteronism more often, such as for all patients with resistant hypertension. Stay tuned for more info on screening and treating primary hyperaldosteronism.

NPS-adv

---

References

1. Khalfallah M, Elsheikh A, Eissa A, Elnagar B. Prevalence, Predictors, and Outcomes of Resistant Hypertension in Egyptian Population. Glob Heart. 2023;18(1):31.
2. Jones DW, Ferdinand KC, Taler SJ, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025 Sep 16;152(11):e114-e218.
3. American Diabetes Association Professional Practice Committee. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2025. Diabetes Care. 2025 Jan 1;48(1 Suppl 1):S207-S238.

---